Cyp4a2 (cytochrome P450, family 4, subfamily a, polypeptide 2) - Rat Genome Database

Send us a Message

Submit Data |  Help |  Video Tutorials |  News |  Publications |  Download |  REST API |  Citing RGD |  Contact   
Gene: Cyp4a2 (cytochrome P450, family 4, subfamily a, polypeptide 2) Rattus norvegicus
No known orthologs.
Symbol: Cyp4a2 (Ensembl: LOC120102953)
Name: cytochrome P450, family 4, subfamily a, polypeptide 2 (Ensembl:cytochrome P450 4A2)
RGD ID: 2479
Description: Enables alkane 1-monooxygenase activity; arachidonic acid binding activity; and arachidonic acid monooxygenase activity. Involved in several processes, including fatty acid metabolic process; icosanoid biosynthetic process; and response to hormone. Predicted to be located in endoplasmic reticulum membrane. Predicted to be active in intracellular membrane-bounded organelle. Biomarker of autosomal recessive polycystic kidney disease. Human ortholog(s) of this gene implicated in hypertension. Orthologous to human CYP4A11 (cytochrome P450 family 4 subfamily A member 11) and CYP4A22 (cytochrome P450 family 4 subfamily A member 22); PARTICIPATES IN cytochrome P450 monooxygenase mediated pathway of arachidonic acid metabolism; linoleic acid metabolic pathway; arachidonic acid metabolic pathway; INTERACTS WITH 1-naphthyl isothiocyanate; 17beta-estradiol; 2,2,2-tetramine.
Type: protein-coding
Previously known as: Cyp4a11; CYPIVA2; cytochrome P-450 K-2; cytochrome P450 4A2; cytochrome P450 4A2-like; cytochrome P450 K-5; cytochrome P450, subfamily 4A, polypeptide 11; Cytochrome P450, subfamily IVA, polypeptide 11; cytochrome P450-LA-omega 2; lauric acid omega-hydroxylase; LOC100365231; long-chain fatty acid omega-monooxygenase; P-450 IV4AII; P-450 K-2; P450 K-5; P450-LA-omega 2
RGD Orthologs
Alliance Genes
More Info homologs ...
Allele / Splice: Cyp4a2em1Mcwi  
Genetic Models: SS-Chr 5BN-Cyp4a2em1Mcwi
Candidate Gene For: Scl14 Rf54
Latest Assembly: mRatBN7.2 - mRatBN7.2 Assembly
Rat AssemblyChrPosition (strand)SourceGenome Browsers
GRCr85134,160,356 - 134,170,908 (-)NCBIGRCr8
mRatBN7.25128,922,355 - 128,934,188 (-)NCBImRatBN7.2mRatBN7.2
mRatBN7.2 Ensembl5128,923,615 - 128,934,165 (-)EnsemblmRatBN7.2 Ensembl
UTH_Rnor_SHR_Utx5131,613,470 - 131,624,036 (-)NCBIRnor_SHRUTH_Rnor_SHR_Utx
UTH_Rnor_SHRSP_BbbUtx_1.05133,368,346 - 133,378,910 (-)NCBIRnor_SHRSPUTH_Rnor_SHRSP_BbbUtx_1.0
UTH_Rnor_WKY_Bbb_1.05133,390,516 - 133,401,078 (-)NCBIRnor_WKYUTH_Rnor_WKY_Bbb_1.0
Rnor_6.05134,196,910 - 134,207,888 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_6.0 Ensembl5134,196,912 - 134,207,863 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_5.05137,989,327 - 138,000,302 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.45135,765,673 - 135,773,006 (-)NCBIRGSC3.4RGSC_v3.4rn4RGSC3.4
RGSC_v3.15135,553,026 - 135,778,567 (-)NCBI
Cytogenetic Map5q35NCBI
JBrowse: View Region in Genome Browser (JBrowse)

Disease Annotations     Click to see Annotation Detail View

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process

Cellular Component


References - curated
# Reference Title Reference Citation
1. Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium. Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
2. Rat ISS GO annotations from GOA human gene data--August 2006 GOA data from the GO Consortium
3. Contribution of cytochrome P450 4A isoforms to renal functional response to inhibition of nitric oxide production in the rat. Hercule HC, etal., J Physiol. 2003 Sep 15;551(Pt 3):971-9. Epub 2003 Jul 11.
4. Structural determination of the substrate specificities and regioselectivities of the rat and human fatty acid omega-hydroxylases. Hoch U, etal., Arch Biochem Biophys. 2000 Jan 1;373(1):63-71.
5. Regulation of renal cytochrome P450s by thyroid hormone in diabetic rats. Imaoka S, etal., Biochem Pharmacol. 1993 Dec 14;46(12):2197-200.
6. Developmentally regulated expression of the CYP4A genes in the spontaneously hypertensive rat kidney. Kroetz DL, etal., Mol Pharmacol. 1997 Sep;52(3):362-72.
7. Cytochrome P-450 4A isoform expression and 20-HETE synthesis in renal preglomerular arteries. Marji JS, etal., Am J Physiol Renal Physiol 2002 Jul;283(1):F60-7.
8. Association of the T8590C polymorphism of CYP4A11 with hypertension in the MONICA Augsburg echocardiographic substudy. Mayer B, etal., Hypertension. 2005 Oct;46(4):766-71. Epub 2005 Sep 6.
9. Differential regulation of endobiotic-oxidizing cytochromes P450 in vitamin A-deficient male rat liver. Murray M, etal., Br J Pharmacol. 2001 Dec;134(7):1487-97. doi: 10.1038/sj.bjp.0704380.
10. Induction of cytochrome P450 isozymes in rat renal microsomes by cyclosporin A. Nakamura M, etal., Biochem Pharmacol. 1994 Nov 1;48(9):1743-6.
11. Kinetic profile of the rat CYP4A isoforms: arachidonic acid metabolism and isoform-specific inhibitors. Nguyen X, etal., Am J Physiol. 1999 Jun;276(6 Pt 2):R1691-700.
12. Chronic blockade of 20-HETE synthesis reduces polycystic kidney disease in an orthologous rat model of ARPKD. Park F, etal., Am J Physiol Renal Physiol. 2009 Jan 7.
13. KEGG Annotation Import Pipeline Pipeline to import KEGG annotations from KEGG into RGD
14. GOA pipeline RGD automated data pipeline
15. Data Import for Chemical-Gene Interactions RGD automated import pipeline for gene-chemical interactions
Additional References at PubMed
PMID:1739747   PMID:2306108   PMID:2766932   PMID:11139583   PMID:12477932   PMID:15280100   PMID:15489334   PMID:16543501   PMID:19675180   PMID:27174801   PMID:27194719  



Variants in Cyp4a2
5 total Variants
miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:57
Count of miRNA genes:49
Interacting mature miRNAs:51
Prediction methods:Miranda, Rnahybrid
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (
For more information about miRGate, see PMID:25858286 or access the full paper here.

QTLs in Region (mRatBN7.2)
The following QTLs overlap with this region.    Full Report CSV TAB Printer Gviewer
RGD IDSymbolNameLODP ValueTraitSub TraitChrStartStopSpecies
70212Niddm25Non-insulin dependent diabetes mellitus QTL 253.54blood glucose amount (VT:0000188)blood glucose level (CMO:0000046)51131345958Rat
1576314Eutr1Estrogen induced uterine response QTL 1uterus integrity trait (VT:0010575)pyometritis severity score (CMO:0002009)52138965166875058Rat
2290448Scl54Serum cholesterol level QTL 542.93blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)531663789131345958Rat
1641912Alcrsp18Alcohol response QTL 18response to alcohol trait (VT:0010489)duration of loss of righting reflex (CMO:0002289)535189153141643988Rat
1549845Scl44Serum cholesterol level QTL 446blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)540128307148607290Rat
1331801Rf33Renal function QTL 334.149kidney blood vessel physiology trait (VT:0100012)absolute change in renal vascular resistance (CMO:0001900)543726656129132602Rat
1578766Tcas11Tongue tumor susceptibility QTL 114.12tongue integrity trait (VT:0010553)number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950)546711509161317411Rat
1576312Emca8Estrogen-induced mammary cancer QTL 84.1mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)550328551141643988Rat
70189Mcs5Mammary carcinoma susceptibility QTL 510.51mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)555805606132207589Rat
61426Scl2Serum cholesterol level QTL 27.30.001blood cholesterol amount (VT:0000180)serum total cholesterol level (CMO:0000363)559793399143070159Rat
61393Bp7Blood pressure QTL 74.50.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)560293434161481680Rat
1354598Srn6Serum renin concentration QTL 63.8blood renin amount (VT:0003349)plasma renin activity level (CMO:0000116)569540295151018848Rat
1302790Scl20Serum cholesterol level QTL 206.40.0001blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)582394392166664054Rat
1298086Bp156Blood pressure QTL 156arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)584132602129132602Rat
7411601Foco12Food consumption QTL 1219.70.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)587468046132468046Rat
7411564Bw135Body weight QTL 1350.001body mass (VT:0001259)body weight gain (CMO:0000420)587468046132468046Rat
7411582Foco3Food consumption QTL 37.50.001eating behavior trait (VT:0001431)feed conversion ratio (CMO:0001312)587468046132468046Rat
6903316Bw113Body weight QTL 11320.0103body mass (VT:0001259)body weight (CMO:0000012)587765973132765973Rat
631527Tls1T-lymphoma susceptibility QTL 100.001thymus integrity trait (VT:0010555)post-insult time to onset of T-cell lymphoma (CMO:0001907)590450144135450144Rat
61452Ciaa5CIA Autoantibody QTL 53.5blood autoantibody amount (VT:0003725)calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281)594858972143070159Rat
1331796Thshl2Thyroid stimulating hormone level QTL 22.3blood thyroid-stimulating hormone amount (VT:0005119)serum thyroid stimulating hormone level (CMO:0001248)597059760147465714Rat
2317753Glom24Glomerulus QTL 243.1kidney glomerulus integrity trait (VT:0010546)kidney sclerotic glomeruli count to total glomeruli count ratio (CMO:0001269)597570330136479578Rat
1358187Emca1Estrogen-induced mammary cancer QTL 14.4mammary gland integrity trait (VT:0010552)post-insult time to mammary tumor formation (CMO:0000345)599216724148607142Rat
1578673Bmd13Bone mineral density QTL 134.9femur mineral mass (VT:0010011)trabecular volumetric bone mineral density (CMO:0001729)5103689353148689353Rat
2317056Wbc3White blood cell count QTL 32.510.01leukocyte quantity (VT:0000217)white blood cell count (CMO:0000027)5105999803150999803Rat
7207488Bss110Bone structure and strength QTL 18.4femur strength trait (VT:0010010)femur stiffness (CMO:0001674)5106906205151906205Rat
7207491Bss112Bone structure and strength QTL 1127femur morphology trait (VT:0000559)femur midshaft cortical cross-sectional area (CMO:0001663)5106906205151906205Rat
7207481Bss106Bone structure and strength QTL 1067.9femur strength trait (VT:0010010)femur ultimate force (CMO:0001675)5106906205151906205Rat
7207486Bss109Bone structure and strength QTL 109femur strength trait (VT:0010010)femur total energy absorbed before break (CMO:0001677)5106906205151906205Rat
1549838Bss4Bone structure and strength QTL 49.2femur strength trait (VT:0010010)femur midshaft polar moment of inertia (CMO:0001669)5106906205151906205Rat
1298089Scl14Serum cholesterol level QTL 145.80.0004blood cholesterol amount (VT:0000180)plasma total cholesterol level (CMO:0000585)5108845856153845856Rat
1598847Cm62Cardiac mass QTL 623.4heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)5108845856153845856Rat
8657050Bw146Body weight QTL 14619.840.001body mass (VT:0001259)body weight gain (CMO:0000420)5108938288153938288Rat
8694441Bw169Body weight QTL 16917.610.001retroperitoneal fat pad mass (VT:0010430)retroperitoneal fat pad weight to body weight ratio (CMO:0000635)5111416838156416838Rat
8694198Abfw3Abdominal fat weight QTL 316.130.001visceral adipose mass (VT:0010063)abdominal fat pad weight to body weight ratio (CMO:0000095)5111416838156416838Rat
8694389Bw160Body weight QTL 1606.170.001body lean mass (VT:0010483)lean tissue morphological measurement (CMO:0002184)5111416838156416838Rat
8552960Pigfal15Plasma insulin-like growth factor 1 level QTL 15blood insulin-like growth factor amount (VT:0010479)plasma insulin-like growth factor 1 level (CMO:0001299)5111416838156416838Rat
1581510Cm54Cardiac mass QTL 543.40.05heart left ventricle mass (VT:0007031)heart left ventricle weight to body weight ratio (CMO:0000530)5120740824143608494Rat
2293642Bss37Bone structure and strength QTL 374.640.0001femur strength trait (VT:0010010)femur ultimate force (CMO:0001675)5120740824151018848Rat
1641920Colcs1Colorectal carcinoma susceptibility QTL 12.990.0055intestine integrity trait (VT:0010554)benign colorectal tumor surface area measurement (CMO:0001799)5121846814166846814Rat
7394710Emca12Estrogen-induced mammary cancer QTL 12mammary gland integrity trait (VT:0010552)mammary tumor number (CMO:0000343)5124160767133749643Rat
10053720Scort26Serum corticosterone level QTL 262.060.0147blood corticosterone amount (VT:0005345)plasma corticosterone level (CMO:0001173)5124965598166875058Rat
1300122Wbc1White blood cell count QTL 12.75leukocyte quantity (VT:0000217)total white blood cell count (CMO:0000365)5125392826139989768Rat
724525Bp147Blood pressure QTL 1474.30.0001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)5126424772166875058Rat
1598819Bp292Blood pressure QTL 2924.3arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)5127798274166875058Rat
1598861Cm64Cardiac mass QTL 642.9heart mass (VT:0007028)heart weight to body weight ratio (CMO:0000074)5127798274166875058Rat
1581505Rf54Renal function QTL 54kidney physiology trait (VT:0002136)kidney 20-HETE level (CMO:0001854)5128033842133011550Rat
8552908Pigfal4Plasma insulin-like growth factor 1 level QTL 46.6blood insulin-like growth factor amount (VT:0010479)plasma insulin-like growth factor 1 level (CMO:0001299)5128506074166875058Rat
8694169Bw148Body weight QTL 14850.001body mass (VT:0001259)body weight gain (CMO:0000420)5128506074166875058Rat
634349Bp139Blood pressure QTL 1390.001arterial blood pressure trait (VT:2000000)systolic blood pressure (CMO:0000004)5128924607166875058Rat

Markers in Region
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.25129,098,900 - 129,099,033 (+)MAPPERmRatBN7.2
mRatBN7.25128,924,597 - 128,924,722 (+)MAPPERmRatBN7.2
Rnor_6.05134,469,641 - 134,469,771NCBIRnor6.0
Rnor_6.05134,197,895 - 134,198,019NCBIRnor6.0
Rnor_5.05138,259,603 - 138,259,733UniSTSRnor5.0
Rnor_5.05137,990,312 - 137,990,436UniSTSRnor5.0
RGSC_v3.45135,877,115 - 135,877,245UniSTSRGSC3.4
Celera5127,636,592 - 127,636,722UniSTS
Cytogenetic Map5q36UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.25129,098,910 - 129,099,034 (+)MAPPERmRatBN7.2
mRatBN7.25128,924,607 - 128,924,723 (+)MAPPERmRatBN7.2
Rnor_6.05134,469,651 - 134,469,772NCBIRnor6.0
Rnor_6.05134,197,905 - 134,198,020NCBIRnor6.0
Rnor_5.05138,259,613 - 138,259,734UniSTSRnor5.0
Rnor_5.05137,990,322 - 137,990,437UniSTSRnor5.0
RGSC_v3.45135,877,125 - 135,877,246UniSTSRGSC3.4
RGSC_v3.45135,877,124 - 135,877,246RGDRGSC3.4
RGSC_v3.15135,882,350 - 135,882,472RGD
Celera5127,636,602 - 127,636,723UniSTS
RH 3.4 Map5837.7RGD
RH 3.4 Map5837.7UniSTS
Cytogenetic Map5q36UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.25147,939,831 - 147,939,945 (+)MAPPERmRatBN7.2
Rnor_6.05154,056,366 - 154,056,479NCBIRnor6.0
Rnor_5.05157,821,821 - 157,821,934UniSTSRnor5.0
RGSC_v3.45154,480,646 - 154,480,760RGDRGSC3.4
RGSC_v3.45154,480,647 - 154,480,760UniSTSRGSC3.4
RGSC_v3.15154,490,686 - 154,490,799RGD
Celera5146,349,162 - 146,349,275UniSTS
RH 3.4 Map5999.3UniSTS
RH 3.4 Map5999.3RGD
RH 2.0 Map5951.1RGD
Cytogenetic Map5q36UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.25129,098,021 - 129,098,201 (+)MAPPERmRatBN7.2
mRatBN7.25128,923,713 - 128,923,893 (+)MAPPERmRatBN7.2
mRatBN7.25129,010,601 - 129,010,781 (+)MAPPERmRatBN7.2
Rnor_6.05134,468,762 - 134,468,941NCBIRnor6.0
Rnor_6.05134,197,011 - 134,197,190NCBIRnor6.0
Rnor_5.05138,258,724 - 138,258,903UniSTSRnor5.0
Rnor_5.05137,989,428 - 137,989,607UniSTSRnor5.0
RGSC_v3.45135,876,236 - 135,876,415UniSTSRGSC3.4
Celera5127,635,713 - 127,635,892UniSTS
RH 3.4 Map5836.4UniSTS
Cytogenetic Map5q36UniSTS
Rat AssemblyChrPosition (strand)SourceJBrowse
mRatBN7.25128,932,273 - 128,932,462 (+)MAPPERmRatBN7.2
mRatBN7.25129,113,516 - 129,113,665 (+)MAPPERmRatBN7.2
mRatBN7.25129,019,159 - 129,019,348 (+)MAPPERmRatBN7.2
Rnor_6.05134,205,972 - 134,206,160NCBIRnor6.0
Rnor_5.05137,998,389 - 137,998,577UniSTSRnor5.0
RGSC_v3.45135,771,115 - 135,771,303UniSTSRGSC3.4
RH 3.4 Map5837.7UniSTS
Cytogenetic Map5q36UniSTS

Genetic Models
This gene Cyp4a2 is modified in the following models/strains:


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system appendage
High 2 2 2 8
Medium 21 21 21 15
Low 20 12 7 12 2 2 1 2 2 7 2
Below cutoff 9 10 2 11 2 6 7 7 4 12 4 6


RefSeq Acc Id: ENSRNOT00000045571   ⟹   ENSRNOP00000045567
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl5128,923,615 - 128,934,165 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000051252   ⟹   ENSRNOP00000042072
Rat AssemblyChrPosition (strand)Source
Rnor_6.0 Ensembl5134,196,912 - 134,207,863 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000083686   ⟹   ENSRNOP00000072485
Rat AssemblyChrPosition (strand)Source
Rnor_6.0 Ensembl5134,197,521 - 134,207,847 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000088209   ⟹   ENSRNOP00000074484
Rat AssemblyChrPosition (strand)Source
Rnor_6.0 Ensembl5134,196,915 - 134,207,859 (-)Ensembl
RefSeq Acc Id: ENSRNOT00000111375   ⟹   ENSRNOP00000082696
Rat AssemblyChrPosition (strand)Source
mRatBN7.2 Ensembl5128,923,615 - 128,934,165 (-)Ensembl
RefSeq Acc Id: NM_001044770   ⟹   NP_001038235
Rat AssemblyChrPosition (strand)Source
GRCr85134,160,356 - 134,170,908 (-)NCBI
mRatBN7.25128,923,613 - 128,934,165 (-)NCBI
Rnor_6.05134,196,910 - 134,207,863 (-)NCBI
Rnor_5.05137,989,327 - 138,000,302 (-)NCBI
RGSC_v3.45135,765,673 - 135,773,006 (-)RGD
Protein Sequences
Protein RefSeqs NP_001038235 (Get FASTA)   NCBI Sequence Viewer  
GenBank Protein AAH78684 (Get FASTA)   NCBI Sequence Viewer  
Ensembl Protein ENSRNOP00000045567.5
GenBank Protein P20816 (Get FASTA)   NCBI Sequence Viewer  
RefSeq Acc Id: NP_001038235   ⟸   NM_001044770
- UniProtKB: Q4G071 (UniProtKB/Swiss-Prot),   P20816 (UniProtKB/Swiss-Prot),   F1M7X1 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: ENSRNOP00000042072   ⟸   ENSRNOT00000051252
RefSeq Acc Id: ENSRNOP00000072485   ⟸   ENSRNOT00000083686
RefSeq Acc Id: ENSRNOP00000074484   ⟸   ENSRNOT00000088209
RefSeq Acc Id: ENSRNOP00000045567   ⟸   ENSRNOT00000045571
RefSeq Acc Id: ENSRNOP00000082696   ⟸   ENSRNOT00000111375

Protein Structures
Name Modeler Protein Id AA Range Protein Structure
AF-P20816-F1-model_v2 AlphaFold P20816 1-504 view protein structure


eQTL   View at Phenogen
WGCNA   View at Phenogen
Tissue/Strain Expression   View at Phenogen

RGD ID:13693917
Promoter ID:EPDNEW_R4442
Type:multiple initiation site
Description:cytochrome P450, family 4, subfamily a, polypeptide 2
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database,
Experiment Methods:Single-end sequencing.
Rat AssemblyChrPosition (strand)Source
Rnor_6.05134,207,875 - 134,207,935EPDNEW

Additional Information

Database Acc Id Source(s)
AGR Gene RGD:2479 AgrOrtholog
BioCyc Gene G2FUF-40290 BioCyc
Ensembl Genes ENSRNOG00000030154 Ensembl
  ENSRNOG00000064139 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  ENSRNOG00000066487 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Transcript ENSRNOT00000045571.6 UniProtKB/TrEMBL
  ENSRNOT00000111375.1 UniProtKB/Swiss-Prot
  ENSRNOT00000115710.1 UniProtKB/Swiss-Prot
  ENSRNOT00000118610.1 UniProtKB/TrEMBL
Gene3D-CATH 1.10.630.10 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
InterPro Cyt_P450 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Cyt_P450_CS UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Cyt_P450_E_grp-I UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  Cyt_P450_sf UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report rno:24306 UniProtKB/Swiss-Prot
  CYTOCHROME P450 FAMILY 4 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Pfam p450 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PhenoGen Cyp4a2 PhenoGen
PRINTS EP450I UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
  P450 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
RatGTEx ENSRNOG00000030154 RatGTEx
  ENSRNOG00000064139 RatGTEx
  ENSRNOG00000066487 RatGTEx
Superfamily-SCOP SSF48264 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt CP4A2_RAT UniProtKB/Swiss-Prot
UniProt Secondary Q4G071 UniProtKB/Swiss-Prot

Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2013-03-29 Cyp4a2  cytochrome P450, family 4, subfamily a, polypeptide 2  LOC100365231  cytochrome P450 4A2-like  Data merged from RGD:2319443 737654 PROVISIONAL
2010-05-05 LOC100365231  cytochrome P450 4A2-like      Symbol and Name status set to provisional 70820 PROVISIONAL
2007-07-06 Cyp4a2  cytochrome P450, family 4, subfamily a, polypeptide 2  Cyp4a11  cytochrome P450, subfamily 4A, polypeptide 11  Name updated 1299863 APPROVED
2002-11-06 Cyp4a11  cytochrome P450, subfamily4A, polypeptide 11    Cytochrome P450, subfamily IVA, polypeptide 11  Name updated 625702 APPROVED
2002-06-10 Cyp4a11  Cytochrome P450, subfamily IVA, polypeptide 11      Symbol and Name status set to approved 70586 APPROVED

RGD Curation Notes
Note Type Note Reference
gene_expression expressed in nephron segments and preglomerular arterioles of the kidneys 628319
gene_function catalyzes the hydroxylation of omega-terminal -carbon of the arachidonic acid to 20-hydroxyeicosatetraenoic acid (20-HETE) 628319
gene_regulation protein expression increases with decreased arterial diameter 628319
gene_transcript possesses a TATA-less promoter 727598